Gritstone Oncology Inc (GRTS)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track Share on 𝕏

Stock chart

Ticker: GRTS Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Search

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value	Details
2023-05-24	2023-05-23	B Purchase	Economides Vassiliki See Remarks Officer	12,000 +5.9% 1.90 22,829 USD	12,000 +5.9%	1.90	22,829 USD
2021-12-03	2021-12-01	PS Planned sale	Jones Erin Chief Operating Officer Officer	1,000 -2.1% 13.01 13,010 USD	1,000 -2.1%	13.01	13,010 USD
2021-11-03	2021-11-01	PS Planned sale	Jones Erin See Remarks Officer	1,000 -4.8% 11.14 11,140 USD	1,000 -4.8%	11.14	11,140 USD
2021-10-05	2021-10-04	PS Planned sale	Jones Erin See Remarks Officer	1,000 -4.8% 10.71 10,710 USD	1,000 -4.8%	10.71	10,710 USD
2021-10-05	2021-10-01	PS Planned sale	Jones Erin See Remarks Officer	1,000 -4.8% 10.68 10,680 USD	1,000 -4.8%	10.68	10,680 USD
2021-06-03	2021-05-27	S Sale	Rousseau Raphael See Remarks Officer	2,900 -100.0% 9.00 26,112 USD	2,900 -100.0%	9.00	26,112 USD
2021-01-21	2021-01-20	PS Planned sale	Rousseau Raphael See Remarks Officer	10,000 -100.0% 25.07 250,705 USD	10,000 -100.0%	25.07	250,705 USD
2021-01-21	2021-01-19	PS Planned sale	Rousseau Raphael See Remarks Officer	20,000 -100.0% 17.53 350,564 USD	20,000 -100.0%	17.53	350,564 USD
2021-01-21	2021-01-19	S Sale	Yelensky Roman See Remarks Officer	10,000 -7.0% 22.10 221,029 USD	10,000 -7.0%	22.10	221,029 USD
2021-01-04	2020-12-30	B Purchase	Woiwode Thomas Non-Executive Director	1,347,709 +inf% 3.71 5,000,000 USD	1,347,709 +inf%	3.71	5,000,000 USD
2019-08-23	2019-08-21	S Sale	Rousseau Raphael See Remarks Officer	10,000 -100.0% 10.76 107,631 USD	10,000 -100.0%	10.76	107,631 USD
2018-10-02	2018-09-28	B Purchase	Simon Nicholas Non-Executive Director Large shareholder	333,333 +inf% 15.00 4,999,995 USD	333,333 +inf%	15.00	4,999,995 USD
2018-10-02	2018-09-28	B Purchase	Clarus Lifesciences III, L.P. Large shareholder	333,333 +inf% 15.00 4,999,995 USD	333,333 +inf%	15.00	4,999,995 USD